Internal Medicine, Rheumatology · La Palma, CA
NPI
1205833662
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5451 la Palma Ave, Suite 25
La Palma, CA, 90623
Phone (714) 670-1340
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.0M
259,620 services
Medicare patients, 2024
1,433
Average age 72
Drug cost, 2024
$15.8M
19,575 prescriptions
Company payments, 2025
$85.68
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gerald Y Ho was code J3262 (injection, tocilizumab, 1 mg), 86,128 times for 28 patients. In total Gerald Y Ho billed 259,620 services in 94 codes, and Medicare paid $4.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 86,128 | 28 | $3.76 | $324K |
| J0897 Injection, denosumab, 1 mg | Office | 26,040 | 307 | $20.48 | $533K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 23,125 | 47 | $24.54 | $567K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 21,455 | 32 | $9.00 | $193K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 17,640 | 17 | $8.62 | $152K |
| J7332 Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg | Office | 14,680 | 160 | $8.05 | $118K |
| J0490 Injection, belimumab, 10 mg | Office | 10,084 | 19 | $12.61 | $127K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 9,912 | 52 | $20.84 | $207K |
| Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | Office | 4,050 | 19 | $16.22 | $66K |
| 99214 Office E&M - Established | Office | 3,209 | 1,251 | $107.77 | $346K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 3,031 | 46 | $0.10 | $312 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,019 | 102 | $0.09 | $266 |
| Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 2,260 | 14 | $20.18 | $46K |
| 96372 Injection Administration | Office | 1,319 | 439 | $12.84 | $17K |
| 20611 Joint Injection | Office | 1,168 | 290 | $73.91 | $86K |
By year: 2022 $3.0M for 244,696 services; 2023 $2.9M for 256,419 services; 2024 $4.0M for 259,620 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gerald Y Ho prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,818 prescriptions and refills. In total Gerald Y Ho wrote 19,575 Medicare prescriptions that cost $15.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,818 | 4,110 | 521 | $72K |
| Methotrexate Methotrexate Sodium | 1,533 | 3,114 | 411 | $40K |
| Prednisone Generic | 1,432 | 2,089 | 374 | $8,425 |
| Diclofenac Sodium Generic | 1,382 | 1,642 | 498 | $345K |
| Sulfasalazine Generic | 877 | 1,861 | 268 | $23K |
| Meloxicam Generic | 811 | 1,321 | 310 | $2,953 |
| Alendronate Sodium Generic | 744 | 1,609 | 237 | $4,950 |
| Baclofen Generic | 728 | 1,558 | 251 | $7,718 |
| Gabapentin Generic | 722 | 1,208 | 218 | $6,699 |
| Ibuprofen Generic | 470 | 617 | 159 | $3,504 |
| Omeprazole Generic | 365 | 853 | 120 | $3,345 |
| Prolia Denosumab | 356 | 2,122 | 246 | $589K |
| Celecoxib Generic | 355 | 512 | 119 | $18K |
| Duloxetine Hcl Generic | 341 | 713 | 116 | $8,545 |
| Mycophenolate Mofetil Generic | 303 | 570 | 69 | $38K |
Brand drugs: 3,963 claims; generic drugs: 15,586 claims; opioid claims: 314.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gerald Y Ho $85.68 ($85.68 in general payments such as food, travel and fees) from 8 companies. The largest payer was Amgen Inc. with $31.28.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.